Global (R)-Duloxetine (CAS 116539-60-7) market was valued at USD 1.87 billion in 2025 and is projected to reach USD 3.64 billion by 2034, exhibiting a remarkable CAGR of 6.8% during the forecast period.  (R)-Duloxetine (CAS 116539-60-7) is the pharmacologically active enantiomer of duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI) widely used in the treatment of major...

The pursuit of "remission" rather than just "management" is the new North Star for researchers in the field of CIDP. Advanced proteomics and genomic sequencing are allowing researchers to identify specific biomarkers that can predict a patient's response to various therapies. This shift toward precision medicine is reducing the "trial and error" phase of treatment, which is often frustrating...

The acquired hemophilia treatment market is witnessing steady growth as healthcare providers increasingly focus on improving the diagnosis and management of this rare autoimmune bleeding disorder. Acquired hemophilia occurs when the body's immune system develops inhibitors against clotting factor VIII, resulting in spontaneous and potentially life-threatening bleeding episodes. Growing...

The adiponectin testing market is gaining momentum as healthcare systems increasingly emphasize early disease detection, preventive care, and precision diagnostics. Adiponectin, a hormone produced by adipose tissue, plays an important role in regulating glucose levels, lipid metabolism, and insulin sensitivity. Growing research linking adiponectin levels with metabolic disorders, cardiovascular...

   Chip on Submount (COS) Market, valued at USD 567.3 million in 2024, is poised for substantial expansion, projected to reach USD 1.14 billion by 2032. This growth trajectory, representing a compound annual growth rate (CAGR) of 10.6% during the forecast period 2025-2032, is detailed in a comprehensive new report published by Semiconductor Insight. The study underscores the...

The Africa cancer targeted therapy market is experiencing significant growth due to the increasing burden of cancer and the rising adoption of precision-based oncology treatments across the region. The Africa Cancer Targeted Therapy Market size is expected to reach US$ 3,477.6 million by 2031 from US$ 1,733.4 million in 2024. The market is estimated to record a CAGR of 10.5% from 2025 to 2031....

The Africa laser ablation market is witnessing steady growth as healthcare providers increasingly adopt minimally invasive treatment technologies to improve patient outcomes and clinical efficiency. Rising awareness of advanced medical procedures, expanding healthcare infrastructure, and increasing demand for precision-based therapies are...

The Asia Pacific non-invasive radiosurgery robots market is experiencing rapid growth due to the increasing demand for advanced cancer treatment technologies and the continuous modernization of healthcare infrastructure across the region. Non-invasive radiosurgery robots are highly sophisticated systems used for delivering precise radiation therapy to tumors and other targeted...

Allergic rhinitis remains one of the most common chronic respiratory conditions worldwide, affecting millions of people across all age groups. Rising exposure to environmental allergens, increasing urbanization, changing climatic conditions, and growing awareness about allergy diagnosis and treatment are contributing to the expansion of the market. Healthcare providers are increasingly focusing...

The alopecia market is experiencing robust growth as the prevalence of hair loss disorders continues to rise worldwide. Increasing awareness of available treatment options, growing demand for aesthetic healthcare solutions, and continuous advancements in dermatology are encouraging more individuals to seek medical intervention for hair loss. Improvements in diagnostic capabilities, expanding...